Peter C. Anastos, Executive Vice President, General Counsel, and Secretary of N-able, Inc. (NYSE:NABL), filed a Form 4 on August 18, 2026, disclosing a transaction in the company's common stock dated August 15, 2026.
A Form 4 filed on August 18, 2026, discloses that Michael I. Adler, Executive Vice President and Chief Technology and Product Officer of N-able, Inc. (NYSE:NABL), disposed of 4,586 shares of common stock on August 15, 2026, to satisfy tax withholding obligations tied to …
Paul F. Lizzul, Chief Medical Officer of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), filed a Form 4 on August 18, 2026, reporting the acquisition of 60,492 performance-based restricted stock units earned upon certification of performance criteria on August 15, 2026.
Benjamin Stone, Chief Business Officer of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), filed a Form 4 on August 18, 2026, disclosing the award of 60,492 performance stock units earned upon certification of achieved performance criteria on August 15, 2026.
Daniel Barber, President and CEO of Aquestive Therapeutics, Inc. (NASDAQ:AQST), filed a Form 4 on August 19, 2026, disclosing the sale of 25,000 shares of common stock on August 17, 2026.
Holly Barbacovi, Chief People Officer of Hasbro, Inc., filed a Form 4 on August 17, 2026, reporting three transactions in Hasbro common stock that occurred on August 15, 2026, all related to the vesting of restricted stock unit awards.
Dawn Christine Maroney, President of Alignment Healthcare, Inc., filed a Form 4 on August 18, 2026, disclosing the sale of 5,000 shares of common stock on August 14, 2026, under a pre-established Rule 10b5-1 trading plan.
Noha Abdalla, Chief Marketing Officer of Choice Hotels International Inc /DE (NYSE:CHH), filed a statement of changes in beneficial ownership on August 18, 2026, disclosing a share disposition dated August 15, 2026.
A Form 4 filed on August 18, 2026, disclosed multiple transactions in Hasbro, Inc. common stock by John Hight, President of WOTC, between August 15 and August 17, 2026.
A Form 4 filed on August 18, 2026 by Freshpet, Inc. Chief Executive Officer and Director William B. Cyr reported the exercise of stock options and sale of common stock on August 14, 2026, across directly and indirectly held accounts.